These data differ from those of a study carried out in the Cameroonian population [8] who found an association between these polymorphisms of the TP63 gene and the Δ32 mutation of the CCR5 gene and the occurrence of breast cancer in women with a family history. This evidence concerns the gene CCR5 and breast carcinoma.